Summit Therapeutics (SMMT) Interest Coverage Ratio: 2016-2024
Historic Interest Coverage Ratio for Summit Therapeutics (SMMT) over the last 3 years, with Dec 2024 value amounting to -7,290.44.
- Summit Therapeutics' Interest Coverage Ratio was N/A to -7,290.44 in Q4 2024 from the same period last year, while for Dec 2024 it was -20.80, marking a year-over-year change of. This contributed to the annual value of -26.02 for FY2024, which is 29.75% up from last year.
- As of Q4 2024, Summit Therapeutics' Interest Coverage Ratio stood at -7,290.44, which was down 30,546.39% from -23.79 recorded in Q3 2024.
- Summit Therapeutics' 5-year Interest Coverage Ratio high stood at -23.79 for Q3 2024, and its period low was -7,290.44 during Q4 2024.
- In the last 1 years, Summit Therapeutics' Interest Coverage Ratio had a median value of -3,657.12 in 2024 and averaged -3,657.12.
- Data for Summit Therapeutics' Interest Coverage Ratio shows a maximum YoY dropped of 14.78% (in 2020) over the last 5 years.
- Quarterly analysis of 2 years shows Summit Therapeutics' Interest Coverage Ratio stood at -116.91 in 2020, then followed by -7,290.44 in 2024.
- Its Interest Coverage Ratio stands at -7,290.44 for Q4 2024, versus -23.79 for Q3 2024 and -116.91 for Q1 2020.